Intervention
glimepiride
ClinicalTrials.gov intervention label
Clinical trials
32 shownA Study to Evaluate the Renal Protective Effect (Urine Albumin-to-Creatinine Ratio (UACR)), Efficacy and Safety of Ipragliflozin in Type 2 Diabetes Mellitus Patients With AlbuminuriaNCT03118713 · 2017-04-25
TERMINATEDSaxagliptin's Effects on Microalbuminuria Improvement in Type 2 Diabetic PatientsNCT02462369 · 2015-06-01
UNKNOWNGlycemic Excursions in Type 2 Diabetic Patients With Vildagliptin and Metformin Versus Vildagliptin and GlimepirideNCT02007278 · 2014-01-03
COMPLETEDEfficacy/Safety Study of Glimepiride to Type 2 Diabetes Patients Based on Metformin And Basal Insulin TreatmentNCT02026310 · 2014-01-01
COMPLETEDA Study to Evaluate ITCA 650 Compared to Glimepiride for the Treatment of Type 2 DiabetesNCT01455883 · 2013-02-01
WITHDRAWNA Study to Evaluate ITCA 650 Compared to Glimepiride as Add on Therapy for the Treatment of Type 2 DiabetesNCT01455922 · 2013-02-01
WITHDRAWNLiraglutide and Heart Failure in Type 2 DiabetesNCT01425580 · 2012-01-01
COMPLETEDComparison of Two Treatment Regimens (Sitagliptin Versus Liraglutide) on Participants Who Failed to Achieve Good Glucose Control on Metformin Alone (MK-0431-403)NCT01296412 · 2011-03-11
COMPLETEDCAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 DiabetesNCT01243424 · 2010-11-11
COMPLETEDComparison of the Blood Sugar Lowering Effect of Biphasic Insulin Aspart 30 and Insulin Glargine Both Combined With Metformin and Glimepiride in Chinese and Japanese Subjects With Type 2 Diabetes New to Insulin TreatmentNCT01123980 · 2010-05-01
COMPLETEDAn Efficacy and Safety Study of Fixed-dose Rosiglitazone/Glimepiride to Treat Chinese Type 2 Diabetes PatientsNCT01453049 · 2010-04-01
TERMINATEDEffect of Sitagliptin on Postprandial Lipoprotein MetabolismNCT00939939 · 2010-03-01
TERMINATEDEffect of Oral Combination Therapy in a Single Dosage Form in Patients With Type 2 Diabetes MellitusNCT00941161 · 2009-02-01
COMPLETEDA Study to Determine the Safety and Efficacy of Albiglutide in Subjects With Type 2 DiabetesNCT00839527 · 2009-02-01
COMPLETEDEfficacy and Safety of Albiglutide in Treatment of Type 2 DiabetesNCT00838903 · 2009-02-01
COMPLETEDThe Effect of Liraglutide on Endothelial Function in Subjects With Type 2 Diabetes MellitusNCT00620282 · 2008-02-01
COMPLETEDEffect of Liraglutide or Glimepiride Added to Metformin on Blood Glucose Control in Subjects With Type 2 DiabetesNCT00614120 · 2008-01-01
COMPLETEDComparison of Biphasic Insulin Aspart 30 Versus Insulin Glargine Both in Combination With Metformin and Glimepiride in Subjects With Type 2 DiabetesNCT00469092 · 2007-05-01
COMPLETEDEfficacy and Safety of Inhaled Insulin Compared to Metformin and Glimepiride in Type 2 DiabetesNCT00469586 · 2007-04-26
TERMINATEDEffect of Inhaled Pre-prandial Human Insulin on Blood Glucose Control in Type 2 DiabetesNCT00427154 · 2007-01-10
TERMINATEDSafety and Efficacy of Inhaled Pre-prandial Human Insulin in Type 2 DiabetesNCT00343980 · 2006-10-10
TERMINATEDExenatide Versus Glimepiride in Patients With Type 2 DiabetesNCT00359762 · 2006-09-01
COMPLETEDTo Compare the Effect of Liraglutide When Given Together With Metformin With the Effect of Metformin Given Alone and With the Effect of Glimepiride and Metformin Given TogetherNCT00318461 · 2006-05-01
COMPLETEDEffect of Liraglutide on Blood Glucose Control in Subjects With Type 2 DiabetesNCT00331851 · 2006-05-01
COMPLETEDEffect of Liraglutide on Blood Glucose Control in Subjects With Type 2 DiabetesNCT00318422 · 2006-05-01
COMPLETEDTo Evaluate the Effect of Liraglutide Versus Glimepiride (Amaryl®) on Haemoglobin A1cNCT00294723 · 2006-02-01
TERMINATEDEffect of Liraglutide Compared to Glimepiride on Appetite in Subjects With Type 2 DiabetesNCT01511692 · 2005-11-01
COMPLETEDVildagliptin Compared to Glimepiride in Combination With Metformin in Patients With Type 2 DiabetesNCT00106340 · 2005-03-01
COMPLETEDEfficacy and Safety of Biphasic Insulin Aspart 30 in Combination With Metformin in Type 2 DiabetesNCT00619697 · 2003-12-01
COMPLETEDGlimepiride vs Metformin as Monotherapy in Pediatric Subjects With Type 2 Diabetes MellitusNCT00353691 · 2002-10-01
COMPLETEDEffect of Liraglutide as add-on to Metformin Compared to Either Liraglutide or Metformin Alone, or to a Combination of Metformin and a SU (Sulphonylurea) Agent in Subjects With Type 2 DiabetesNCT01511172 · 2002-08-01
COMPLETEDComparison of Liraglutide and Glimepiride on Blood Sugar Control in Subjects With Type 2 DiabetesNCT01509755 · 2000-10-01
COMPLETEDCommon conditions
Leading sponsors
Novo Nordisk A/S15GlaxoSmithKline3Intarcia Therapeutics2Novartis Pharmaceuticals2Astellas Pharma Korea, Inc.1AstraZeneca1Boehringer Ingelheim1Laboratorios Silanes S.A. de C.V.1Ludwig-Maximilians - University of Munich1Merck Sharp & Dohme LLC1Qifu Li1Sanofi1The Second Hospital of Nanjing Medical University1Thomas Nystrom1
Trial status mix
COMPLETED22
TERMINATED7
WITHDRAWN2
UNKNOWN1
Phase mix
PHASE319
PHASE48
PHASE23
NA1
PHASE11
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.